Kinetics of GLUT4 Trafficking in Rat and Human Skeletal Muscle
- Håkan K.R. Karlsson1,
- Alexander V. Chibalin1,
- Heikki A. Koistinen1,2,3,
- Jing Yang4,
- Francoise Koumanov4,
- Harriet Wallberg-Henriksson5,
- Juleen R. Zierath1 and
- Geoffrey D. Holman4
- 1Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden;
- 2Department of Medicine, Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland;
- 3Minerva Foundation Institute for Medical Research, Biomedicum 2U Helsinki, Helsinki, Finland;
- 4Department of Biology and Biochemistry, University of Bath, Bath, U.K.;
- 5Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
- Corresponding author: Geoffrey D. Holman, g.d.holman{at}bath.ac.uk.
Abstract
OBJECTIVE In skeletal muscle, insulin stimulates glucose transport activity three- to fourfold, and a large part of this stimulation is associated with a net translocation of GLUT4 from an intracellular compartment to the cell surface. We examined the extent to which insulin or the AMP-activated protein kinase activator AICAR can lead to a stimulation of the exocytosis limb of the GLUT4 translocation pathway and thereby account for the net increase in glucose transport activity.
RESEARCH DESIGN AND METHODS Using a biotinylated photoaffinity label, we tagged endogenous GLUT4 and studied the kinetics of exocytosis of the tagged protein in rat and human skeletal muscle in response to insulin or AICAR. Isolated epitrochlearis muscles were obtained from male Wistar rats. Vastus lateralis skeletal muscle strips were prepared from open muscle biopsies obtained from six healthy men (age 39 ± 11 years and BMI 25.8 ± 0.8 kg/m2).
RESULTS In rat epitrochlearis muscle, insulin exposure leads to a sixfold stimulation of the GLUT4 exocytosis rate (with basal and insulin-stimulated rate constants of 0.010 and 0.067 min−1, respectively). In human vastus lateralis muscle, insulin stimulates GLUT4 translocation by a similar sixfold increase in the exocytosis rate constant (with basal and insulin-stimulated rate constants of 0.011 and 0.075 min−1, respectively). In contrast, AICAR treatment does not markedly increase exocytosis in either rat or human muscle.
CONCLUSIONS Insulin stimulation of the GLUT4 exocytosis rate constant is sufficient to account for most of the observed increase in glucose transport activity in rat and human muscle.
Footnotes
-
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Received November 5, 2008.
- Accepted January 19, 2009.
-
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
- © 2009 by the American Diabetes Association.














